Review · Not a partner
$249 buys one month of compounded semaglutide on TMates' own product page. Its app quotes $199 for the same drug, and the two ladders disagree at every term but one.
They advertise
A month with no commitment
$249/mo, month to month
Price read from TMates's own page
Not a partner. Links to TMates go to their own site and pay us nothing. Who pays us.
Compare every priced provider →TMates sells compounded semaglutide and tirzepatide, injectable or oral, next to phentermine, minoxidil, NAD+, testosterone, sermorelin and an erectile-support line. It also sells something unusual, and the wording matters: a prescription for brand Zepbound or Wegovy with no medication attached.
It runs two storefronts at once — a product catalog at tmates.com and an app at app.tmates.com — and for semaglutide they do not quote the same prices.
The gap
They advertise $158 a month. That is the 12 months, $1,900 on the card today. With no commitment it is $249 a month.
| Plan | Per month | Charged today |
|---|---|---|
1 MonthSourceChoose Your Plan 1 Month $249https://tmates.com/products/semaglutide — read 2026-09-02 | $249 | $249 |
3 MonthsSource3 Months$217/mo Save 13% $650https://tmates.com/products/semaglutide — read 2026-09-02 | $217 | $650 |
6 MonthsSource6 Months$175/mo Save 30% $1050https://tmates.com/products/semaglutide — read 2026-09-02 | $175 | $1,050 |
12 Months · advertisedSource12 Months$158/mo Save 37% $1900https://tmates.com/products/semaglutide — read 2026-09-02 | $158 | $1,900 |
⛔ These are the product page's prices. TMates' own app quotes a different ladder for the same drug — $199 a month, $500 for three months, $1,149 for six and $1,899 for twelve — with those totals printed on its checkout under the word TOTAL. Three of the four disagree with the page above, and the app is cheaper at one and three months and dearer at six. Every dose costs the same either way; the term is what moves the price.
| Plan | Per month | Charged today |
|---|---|---|
1 MonthSourceChoose Your Plan 1 Month $297https://tmates.com/products/tirzepatide — read 2026-09-02 | $297 | $297 |
3 MonthsSource3 Months$267/mo Save 10% $800https://tmates.com/products/tirzepatide — read 2026-09-02 | $267 | $800 |
6 MonthsSource6 Months$217/mo Save 27% $1299https://tmates.com/products/tirzepatide — read 2026-09-02 | $217 | $1,299 |
12 MonthsSource12 Months$167/mo Save 44% $1999https://tmates.com/products/tirzepatide — read 2026-09-02 | $167 | $1,999 |
Tirzepatide is the one product whose two surfaces agree: the app's plan screen shows the same $297, $267, $217 and $167 the product page does. Its charged-today totals were not carried to a checkout, so the figures here are the product page's own.
$249 for one month of compounded semaglutide, $297 for tirzepatide. Buying longer drops both: semaglutide is $650 for three months, $1,050 for six, $1,900 for twelve.
⛔ Then the app quotes something else. TMates' own plan screen at app.tmates.com prices the same semaglutide at $199 a month, and its checkout prints the totals under the word TOTAL: $199 monthly, $500 for three months, $1,149 for six, $1,899 for twelve. Against the product page's $249, $650, $1,050 and $1,900, three of the four disagree — and the app is $50 cheaper on a single month while being $99 dearer on six.
Tirzepatide is quoted identically on both surfaces, which is what makes the semaglutide gap hard to read as a rounding difference.
A third monthly figure exists and appears only at the checkout, in the line describing the plan you just chose: “12 months upfront after $197/monthly”. Not $249, not $199.
The ladder does not fall as the term rises. On the app screen three months is $167 a month and six months is $192 — the longer plan costs more per month than the shorter one.
⛔ Read the subscription agreement on the checkout screen before signing it. On the twelve-month plan it says: “I will be charged $1899 for my first 30 day supply and $1899 every 30 days thereafter until I cancel.” Three lines above, the same screen calls that plan “12 months upfront”. The three- and six-month agreements are worded the same way, each naming its own full total as a recurring 30-day charge.
The refund policy leaves no room afterwards: refunds are refused once the medical team has reviewed, the patient qualifies and a prescription has gone to a pharmacy. That applies to the $1,899.
And the brand line is not what a listing page makes it look like. Zepbound and Wegovy appear at “$99 /month” on the shop and weight-loss category pages. The product page adds what that buys: “Includes clinical evaluation & prescription management”, “Clinical Service Only”, and a prescription “delivered directly to your pharmacy”. The $99 is the service. The drug is a separate bill from whoever fills it.
The full breakdown — what is included, what is extra, and what happens at higher doses — is on the TMates cost page.
Anyone who wants one price for one drug. TMates quotes semaglutide at $249 on its product page and $199 in its app, and a third figure, $197, at the checkout.
Anyone buying the six-month plan to save. On the app's own ladder it costs more per month than the three-month plan.
Anyone signing the twelve-month agreement without reading it. Its wording bills the full $1,899 every thirty days until canceled.
Anyone reading the $99 Zepbound or Wegovy listing as a medication price. It buys a prescription and a consultation, and the pharmacy bills the drug separately.
These are the checks this site applies to every company — how we review. Not stated means we could not find it on their site, which is a finding about the site, not about the company.
Read September 2, 2026. Twenty-one tmates.com pages — home, about, our-doctors, contact, terms, privacy, testimonials, how-it-works, shop, five category pages and five product pages — plus 29 screens of the app intake at app.tmates.com and four separate checkout captures, one per semaglutide rung. tmates.com returns 403 to a plain fetch and 200 to a real browser; every figure here was read in a browser. No card details were entered and no order was placed.
The product-page ladder, quoted in reading order from https://tmates.com/products/semaglutide: “Choose Your Plan 1 Month $249”, then “3 Months$217/mo Save 13% $650”, then “6 Months$175/mo Save 30% $1050”, then “12 Months$158/mo Save 37% $1900”. The tirzepatide page carries the same block: “Choose Your Plan 1 Month $297”, “3 Months$267/mo Save 10% $800”, “6 Months$217/mo Save 27% $1299” and “12 Months$167/mo Save 44% $1999”. The per-month figures run into the term with no space, as printed.
★ The app's ladder, quoted in reading order from the plan screen at app.tmates.com/overhaul/choose: “Semaglutide”, “starting dosage 0.25mg/shot”, “Same active ingredient as Ozempic® and Wegovy®”, “$199/mo”, “MONTHLY”, “$167/mo”, “3 MONTHS”, “$192/mo”, “6 MONTHS”, “SAVE 20%”, “$158/mo”, “12 MONTHS”. Tirzepatide on the same screen reads “$297/mo MONTHLY”, “$267/mo 3 MONTHS”, “$217/mo 6 MONTHS”, “$167/mo 12 MONTHS” — matching its product page exactly.
The checkout totals, one capture per rung, quoted from app.tmates.com/overhaul/checkout-v2. Twelve months: “Semaglutide Injection (12 Months)”, “injectable”, “$1899”, “Plan type”, “12 months upfront after $197/monthly”, “Starting dosage”, “2.5mg”, “Subtotal”, “$1899”, “Shipping”, “FREE”, “Ships within”, “24 hours”, “TOTAL”, “$1899”. The monthly capture reads “Semaglutide Injection Level 1 (Monthly)”, “injectable”, “$199”, “Plan type”, “monthly”, “Starting dosage”, “0.25mg”, “TOTAL”, “$199”. Three months totals $500 and six months $1149.
⛔ The subscription agreement, quoted in full from the twelve-month checkout: “I will be charged $1899 for my first 30 day supply and $1899 every 30 days thereafter until I cancel.” The monthly, three- and six-month agreements are identical in form, each naming its own total: $199, $500 and $1149 “every 30 days thereafter”. A 30-day cycle is not a calendar month and drifts about five days forward across a year; what the twelve-month wording says about a $1,899 charge is a question for TMates rather than something this page will assert about its billing.
A dose label that belongs to the other molecule. All three multi-month semaglutide checkouts print “Starting dosage 2.5mg”, which is the tirzepatide starting dose. The monthly semaglutide checkout correctly prints 0.25mg.
The brand line, quoted from https://tmates.com/products/zepbound: “$99”, “/month”, “Includes clinical evaluation & prescription management”, “Clinical Service Only”, and from the page's own description, “Connect with a licensed provider and get a prescription for Zepbound® delivered directly to your pharmacy.” The shop and weight-loss category pages list it at “$99 /month” with none of those qualifiers. No brand rung appears on the ladder above, because TMates does not sell the medication.
Oral and injectable are priced the same on the product pages — switching the Format control changes only the dosage list — but the app's plan screen showed oral tirzepatide at $167 a month on the three-month rung against $267 for the injectable on the same screen. Captured three times.
Numbers the site gives for itself, which do not agree: “70 K+ Happy Patients” on the home page, “(2,400+ patients)” on the product pages, “over 40k users” in the app intake, “Join 28,656+ weight loss patients” at the checkout, and “100k+ Orders Fulfilled” on the about page.
Insurance, both ways. A product-page FAQ says “In general yes, TMates accepts most major insurance plans”; the home page says “No Insurance required. No Waitlist. No Hidden Fees.”
What it says about its own supply, quoted from the sitewide footer: “TMates is not a 503A or 503B compounding facility.” and “TMates may offer compounded medications from registered U.S Pharmacies.” The about page separately calls the company “an online pharmacy” and says “As a manufacturer, we ensure that our products meet the highest standards.”
The entity: “TMates Inc.”, from the terms and the footer, which prints it as “© 2026 TMates Inc.. All Rights Reserved.” with the doubled period. No physical address is published on the terms, privacy, contact or about pages. Governing law is Florida, with arbitration in Miami-Dade County. The terms name the site as try.TMates.com rather than tmates.com.
Screened against FDA's published enforcement index on September 2, 2026 and nothing is filed against this company. The screen ran over all 3,664 letters on the strings TMates and TMates Inc and returned no match; the same screen in the same pass returns the three letters this roster already carries for Hims, Hers and Levity.
What is not on these pages, and the strings searched for it. Across the 21 pages, the terms and privacy policy, and 29 intake screens, “licensed in”, “your state”, “state in which” and “licensed to practice” return no statement that the prescriber is licensed where the patient is; the nearest is “Our Board-certified, US-based physicians.” No pharmacy is named anywhere. On fulfillment the terms restrict where the site is offered rather than where medication comes from — “TMates makes no representation that all products, services, and/or material described on the Site … are appropriate or available for use in locations outside the United States” — so that row reads Not stated rather than Domestic.
The same molecules at every other company we have reviewed, with the range each one falls in.
Words used above: Compounded, 503A, 503B, Overseas fulfillment. All of them are in the glossary.
Not a partner. This link goes to TMates and pays us nothing. Who pays us.
Every company we have reviewed is on the reviews index. See who writes these reviews. Your privacy choices and the terms of use apply to this page.